Skip to main content
. 2013 Sep 24;122(23):3735–3740. doi: 10.1182/blood-2013-06-498303

Table 1.

VWD classification and pathogenetic mechanisms

VWD subtype Pathogenetic mechanisms
Type 1 VWD • ∼65% of index cases have candidate VWF mutations
• ∼70% of VWF variants are missense substitutions influencing VWF trafficking, storage, secretion, and clearance
• Additional transcription and splicing VWF mutations
Type 2A VWD • Missense variants in D1/D2/D′D3 assemblies, A2 and CTCK domains
• Interference with HMW multimer formation, storage, and secretion
• Enhanced ADAMTS13 proteolysis
Type 2B VWD • Missense variants in A1 domain
• Enhanced binding to GPIbα
Type 2M VWD • Missense variants in A1 and A3 domains
• Reduced binding to GPIbα (A1 domain) or collagen (A3 domain)
Type 2N VWD • Missense variants in D′D3 assembly
• Reduced FVIII binding
Type 3 VWD VWF mutations found in 85%-90% of index cases
VWF deletions, nonsense, splice site, and missense mutations